Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Originating from aerospace technology, Bio2 Technologies’ Vitrium biomaterial platform is designed for multiple applications across musculoskeletal surgery. The firm has already begun commercialization in the US and expects to get a CE mark later this year.
Latest From Innovation
Device Debuts is a new regular feature highlighting Medtech Insight editors’ top picks of medical devices that have been commercialized for the first time in the last month. This edition features an innovative minimally invasive surgical stapler, a pain-free blood-collection device, a novel approach for collecting, circulating tumor cells, a rapid fluid-infusion device for critically ill patients, and an EP-mapping and navigation system.
On this week's Medtech Insight podcast: the response by a US FDA advisory panel to Claret Medical's de novo submission for the first brain-filter device intended to protect patients undergoing transcatheter aortic heart-valve replacement; a reporting trip to the Israeli innovation hub; a Boston Scientific recall; and bariatric surgery data.
The medtech giant announced 6% revenue growth, led by the cardiac and vascular and diabetes groups, both of which are enjoying strong market demand for new products. Medtronic expects to continue growing revenues by about five percent annually to maintain double-digit earnings growth.
Siemens Healthineers is set to launch a new digital platform for healthcare providers and technology companies to share data, applications and services. The company presented a prototype of the new digital platform at the Healthcare Information and Management Systems Society (HIMSS) healthcare IT conference in Orlando, Florida.
A new implantable cell-based monitoring device that measure cellular interactions in vivo could soon reach the research market to help medical device and pharma companies in their preclinical, and later this year clinical, research. After that, the technology's developer, Efferent Labs, will be setting its sights on clinical applications like chemotherapy monitoring in cancer patients.
An Israeli start-up developing an injectable, miniature continuous blood glucose monitoring implant has secured funding from the Juvenile Diabetes Research Foundation (JDRF) to speed up product development. The investment will be used to bring GluSense closer to its first in-human clinical trial.
The number of 510(k) clearances in January by US FDA were lower than average, but there was at least one practice-changing advance deemed substantially equivalent last month: Roche's high-sensitivity Elecsys cardiac troponin assay. There were four original PMAs approved in January, but a lower-than-usual total of supplement approvals.
Abbott Laboratories' diagnostic business is rolling out its new line of Alinity systems across its core lab, point-of-care, and molecular markets. Executive VP Brian Blaser says the systems are the realization of an ongoing customer-centric shift by the business, and the firm highlights a turnaround for a diagnostics unit that, only a decade ago, Abbott was trying to wash its hands of.
Swiss start-up Abionic has CE marked rapid tests for sepsis and iron deficiency, designed to run on its diagnostics platform abioSCOPE. The new sepsis test is based on a new biomarker PSP which has shown to be superior to current tests in detecting this life threatening condition early.
You must sign in to use this functionality.
Please Sign In
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with active subscriptions will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.